Acorda Therapeutics
ACOR
#10565
Rank
A$1.23 M
Marketcap
A$1.00
Share price
0.00%
Change (1 day)
-95.76%
Change (1 year)

Acorda Therapeutics (ACOR) - Total debt

Total debt on the balance sheet as of March 2024 : A$0.29 Billion

According to Acorda Therapeutics 's latest financial reports the company's total debt is A$0.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Acorda Therapeutics - Total debt on balance sheet (from 2003 to 2024)

Total debt by year

Year Total debt Change
2022-12-31A$0.25 B-3.52%
2021-12-31A$0.26 B-22.09%
2020-12-31A$0.33 B-5.18%
2019-12-31A$0.35 B-26.94%
2018-12-31A$0.48 B13.68%
2017-12-31A$0.42 B-6.53%
2016-12-31A$0.45 B14.31%
2015-12-31A$0.40 B12.99%
2014-12-31A$0.35 B7155.12%
2013-12-31A$4.9 M-5.46%
2012-12-31A$5.18 M-16.6%
2011-12-31A$6.21 M-18.21%
2010-12-31A$7.6 M-11.89%
2009-12-31A$8.62 M-15.96%
2008-12-31A$10.26 M30.24%
2007-12-31A$7.88 M-19.72%
2006-12-31A$9.81 M-34.59%
2005-12-31A$15.01 M30.98%
2004-12-31A$11.46 M1.23%
2003-12-31A$11.32 M
2003-06-30A$13.22 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Repligen
RGEN
A$1.03 B 251.61%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.90 B 208.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
A$21.6 M-92.67%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Sarepta Therapeutics
SRPT
A$1.88 B 538.11%๐Ÿ‡บ๐Ÿ‡ธ USA